Genetics of Pancreatic Neoplasms and Role of Screening

Venkata Katabathina, Omid Y. Rikhtehgar, Anil K. Dasyam, Rohan Manickam, Srinivasa R. Prasad

Research output: Contribution to journalArticle

Abstract

There is a wide spectrum of pancreatic neoplasms with characteristic genetic abnormalities, tumor pathways, and histopathology that primarily determine tumor biology, treatment response, and prognosis. Although most pancreatic tumors are sporadic, 10% of neoplasms occur in the setting of distinct hereditary syndromes. Detailed studies of these rare syndromes have allowed researchers to identify a myriad of specific genetic signatures of pancreatic tumors. A better understanding of tumor genomics may have significant clinical implications in the diagnosis and management of patients with pancreatic tumors. Evolving knowledge has paved the way to screening paradigms and protocols in individuals at higher risk of developing pancreatic tumors.

Original languageEnglish (US)
JournalMagnetic Resonance Imaging Clinics of North America
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Pancreatic Neoplasms
Neoplasms
Genomics
Research Personnel

Keywords

  • Genomics
  • Neuroendocrine neoplasm
  • Pancreatic ductal adenocarcinoma
  • Screening
  • Serous cystadenoma
  • Solid-pseudopapillary tumor

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Katabathina, V., Rikhtehgar, O. Y., Dasyam, A. K., Manickam, R., & Prasad, S. R. (Accepted/In press). Genetics of Pancreatic Neoplasms and Role of Screening. Magnetic Resonance Imaging Clinics of North America. https://doi.org/10.1016/j.mric.2018.03.005

Genetics of Pancreatic Neoplasms and Role of Screening. / Katabathina, Venkata; Rikhtehgar, Omid Y.; Dasyam, Anil K.; Manickam, Rohan; Prasad, Srinivasa R.

In: Magnetic Resonance Imaging Clinics of North America, 01.01.2018.

Research output: Contribution to journalArticle

Katabathina, Venkata ; Rikhtehgar, Omid Y. ; Dasyam, Anil K. ; Manickam, Rohan ; Prasad, Srinivasa R. / Genetics of Pancreatic Neoplasms and Role of Screening. In: Magnetic Resonance Imaging Clinics of North America. 2018.
@article{9b862d22cbb74bb095d51b11f16016a7,
title = "Genetics of Pancreatic Neoplasms and Role of Screening",
abstract = "There is a wide spectrum of pancreatic neoplasms with characteristic genetic abnormalities, tumor pathways, and histopathology that primarily determine tumor biology, treatment response, and prognosis. Although most pancreatic tumors are sporadic, 10{\%} of neoplasms occur in the setting of distinct hereditary syndromes. Detailed studies of these rare syndromes have allowed researchers to identify a myriad of specific genetic signatures of pancreatic tumors. A better understanding of tumor genomics may have significant clinical implications in the diagnosis and management of patients with pancreatic tumors. Evolving knowledge has paved the way to screening paradigms and protocols in individuals at higher risk of developing pancreatic tumors.",
keywords = "Genomics, Neuroendocrine neoplasm, Pancreatic ductal adenocarcinoma, Screening, Serous cystadenoma, Solid-pseudopapillary tumor",
author = "Venkata Katabathina and Rikhtehgar, {Omid Y.} and Dasyam, {Anil K.} and Rohan Manickam and Prasad, {Srinivasa R.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.mric.2018.03.005",
language = "English (US)",
journal = "Magnetic Resonance Imaging Clinics of North America",
issn = "1064-9689",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Genetics of Pancreatic Neoplasms and Role of Screening

AU - Katabathina, Venkata

AU - Rikhtehgar, Omid Y.

AU - Dasyam, Anil K.

AU - Manickam, Rohan

AU - Prasad, Srinivasa R.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - There is a wide spectrum of pancreatic neoplasms with characteristic genetic abnormalities, tumor pathways, and histopathology that primarily determine tumor biology, treatment response, and prognosis. Although most pancreatic tumors are sporadic, 10% of neoplasms occur in the setting of distinct hereditary syndromes. Detailed studies of these rare syndromes have allowed researchers to identify a myriad of specific genetic signatures of pancreatic tumors. A better understanding of tumor genomics may have significant clinical implications in the diagnosis and management of patients with pancreatic tumors. Evolving knowledge has paved the way to screening paradigms and protocols in individuals at higher risk of developing pancreatic tumors.

AB - There is a wide spectrum of pancreatic neoplasms with characteristic genetic abnormalities, tumor pathways, and histopathology that primarily determine tumor biology, treatment response, and prognosis. Although most pancreatic tumors are sporadic, 10% of neoplasms occur in the setting of distinct hereditary syndromes. Detailed studies of these rare syndromes have allowed researchers to identify a myriad of specific genetic signatures of pancreatic tumors. A better understanding of tumor genomics may have significant clinical implications in the diagnosis and management of patients with pancreatic tumors. Evolving knowledge has paved the way to screening paradigms and protocols in individuals at higher risk of developing pancreatic tumors.

KW - Genomics

KW - Neuroendocrine neoplasm

KW - Pancreatic ductal adenocarcinoma

KW - Screening

KW - Serous cystadenoma

KW - Solid-pseudopapillary tumor

UR - http://www.scopus.com/inward/record.url?scp=85048148971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048148971&partnerID=8YFLogxK

U2 - 10.1016/j.mric.2018.03.005

DO - 10.1016/j.mric.2018.03.005

M3 - Article

C2 - 30376976

AN - SCOPUS:85048148971

JO - Magnetic Resonance Imaging Clinics of North America

JF - Magnetic Resonance Imaging Clinics of North America

SN - 1064-9689

ER -